{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:57:11Z","timestamp":1778738231879,"version":"3.51.4"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Symbiosis International"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01684-z","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:26:06Z","timestamp":1770708366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-8397","authenticated-orcid":false,"given":"Suresh Babu","family":"Kondaveeti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8533-7432","authenticated-orcid":false,"given":"Vrinda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-1614","authenticated-orcid":false,"given":"V. K.","family":"Arunprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshay","family":"kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-383X","authenticated-orcid":false,"given":"Neeraj","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6598-4675","authenticated-orcid":false,"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"6","key":"1684_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.2174\/0109298673281283240101053940","volume":"32","author":"S Abdullaeva","year":"2025","unstructured":"Abdullaeva S, Chubarev V, Valeeva A, Preferanskaya N, Neganova M, Smolyarchuk E, Liu J, Sukocheva O, Samsonov M, Alyautdin R (2025) Analysis of clinical success and molecular mechanisms of action of novel anti-glioblastoma drugs: a review. Curr Med Chem 32(6):1082\u20131102. https:\/\/doi.org\/10.2174\/0109298673281283240101053940","journal-title":"Curr Med Chem"},{"issue":"3","key":"1684_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5603\/cd.104962","volume":"14","author":"P Agrawal","year":"2025","unstructured":"Agrawal P, Gautam A, Prakash C, Garg R, Pursnani N, Yadav S, Panda S, Sharma S, Dantu R (2025) Safety and efficacy of Imeglimin in type 2 diabetes individuals with Metformin intolerance: a case-control study. Clin Diabetol 14(3):154\u2013162. https:\/\/doi.org\/10.5603\/cd.104962","journal-title":"Clin Diabetol"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2016.02.016","volume":"1637","author":"M Akbar","year":"2016","unstructured":"Akbar M, Essa MM, Daradkeh G, Abdelmegeed MA, Choi Y, Mahmood L, Song B-J (2016) Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Res 1637:34\u201355","journal-title":"Brain Res"},{"key":"1684_CR4","first-page":"18","volume":"25","author":"A Alhowail","year":"2021","unstructured":"Alhowail A, Aldubayan M (2021) Recent progress in the Elucidation of the mechanisms of chemotherapy-induced cognitive impairment. Eur Rev Med Pharmacol Sci 25:18","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1684_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prenap.2024.100050","author":"J-J Ang","year":"2024","unstructured":"Ang J-J, Low B-S, Wong P-F (2024) Dopamine and central dopaminergic circuitry in neurodegenerative diseases: roles and mechanisms of action of natural phytochemicals. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.prenap.2024.100050","journal-title":"Pharmacol Res"},{"key":"1684_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111779","author":"SR Archie","year":"2021","unstructured":"Archie SR, Al Shoyaib A, Cucullo L (2021) Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13111779","journal-title":"Pharmaceutics"},{"key":"1684_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101628","volume":"57","author":"KM Asha Spandana","year":"2020","unstructured":"Asha Spandana KM, Bhaskaran M, Karri VVSNR, Natarajan J (2020) A comprehensive review of nano drug delivery system in the treatment of CNS disorders. Journal of Drug Delivery Science and Technology 57:101628. https:\/\/doi.org\/10.1016\/j.jddst.2020.101628","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1","key":"1684_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01930-2","volume":"17","author":"F Atabi","year":"2025","unstructured":"Atabi F, Moassesfar M, Nakhaie T, Bagherian M, Hosseinpour N, Hashemi M (2025) A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer\u2019s disease. Diabetol Metab Syndr 17(1):356. https:\/\/doi.org\/10.1186\/s13098-025-01930-2","journal-title":"Diabetol Metab Syndr"},{"key":"1684_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116280","volume":"456","author":"M Ataei","year":"2022","unstructured":"Ataei M, Abdollahi M (2022) A systematic review of mechanistic studies on the relationship between pesticide exposure and cancer induction. Toxicol Appl Pharmacol 456:116280. https:\/\/doi.org\/10.1016\/j.taap.2022.116280","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"1684_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s42764-023-00110-8","volume":"4","author":"A Babu","year":"2023","unstructured":"Babu A, Urulangodi M (2023) Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain. Genome Instability Disease 4(6):315\u2013332","journal-title":"Genome Instability Disease"},{"issue":"10","key":"1684_CR11","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56(10):7159\u20137172. https:\/\/doi.org\/10.1007\/s12035-019-1589-z","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1684_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101760","volume":"5","author":"WA Banks","year":"2024","unstructured":"Banks WA, Rhea EM, Reed MJ, Erickson MA (2024) The penetration of therapeutics across the blood-brain barrier: classic case studies and clinical implications. Cell Rep Med 5(11):101760. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101760","journal-title":"Cell Rep Med"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.wneu.2021.02.059","volume":"151","author":"M Barbaro","year":"2021","unstructured":"Barbaro M, Fine HA, Magge RS (2021) Foundations of neuro-oncology: a multidisciplinary approach. World Neurosurg 151:392\u2013401","journal-title":"World Neurosurg"},{"issue":"21","key":"1684_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/app152111576","volume":"15","author":"F Barbosa","year":"2025","unstructured":"Barbosa F, Cunha A, Barbosa J, Faria J, Queir\u00f3s O (2025) The dual role of Metformin: repurposing an antidiabetic drug for cancer therapy. Appl Sci 15(21):11576","journal-title":"Appl Sci"},{"key":"1684_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10928-019-09626-7","volume":"46","author":"LZ Benet","year":"2019","unstructured":"Benet LZ, Bowman CM, Koleske ML, Rinaldi CL, Sodhi JK (2019) Understanding drug\u2013drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs. J Pharmacokinet Pharmacodyn 46:155\u2013163","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1684_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091345","author":"R Bilski","year":"2025","unstructured":"Bilski R, D\u0105bkowski S, Kozie\u0142 I, Kozicki M, Ma\u0142achowska A, Przygocki M, Tyska O (2025) Perspectives on Alzheimer\u2019s disease treatment based on counteracting oxidative stress. Biomolecules. https:\/\/doi.org\/10.3390\/biom15091345","journal-title":"Biomolecules"},{"issue":"10","key":"1684_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105377","volume":"25","author":"M Caldarelli","year":"2024","unstructured":"Caldarelli M, Rio P, Marrone A, Ocarino F, Chiantore M, Candelli M, Gasbarrini A, Gambassi G, Cianci R (2024) Gut\u2013brain axis: focus on sex differences in neuroinflammation. Int J Mol Sci 25(10):5377","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1684_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071116","volume":"10","author":"O Cauli","year":"2021","unstructured":"Cauli O (2021) Oxidative stress and cognitive alterations induced by cancer chemotherapy drugs: a scoping review. Antioxidants 10(7):1116","journal-title":"Antioxidants"},{"issue":"8","key":"1684_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biology13080639","volume":"13","author":"ED Cham","year":"2024","unstructured":"Cham ED, Peng T-I, Jou M-J (2024) Pathological role of high sugar in mitochondrial respiratory chain defect-augmented mitochondrial stress. Biology 13(8):639","journal-title":"Biology"},{"key":"1684_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153757","volume":"503","author":"M Chen","year":"2024","unstructured":"Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L, Zhou H, Jiang H, Ma Z (2024) Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology 503:153757. https:\/\/doi.org\/10.1016\/j.tox.2024.153757","journal-title":"Toxicology"},{"key":"1684_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2025.101161","author":"W Chen","year":"2025","unstructured":"Chen W, Johnston IN (2025) A systematic review of the neurobiological mechanisms of chemotherapy-induced deficits in executive functions. Brain Behav Immun - Health. https:\/\/doi.org\/10.1016\/j.bbih.2025.101161","journal-title":"Brain Behav Immun - Health"},{"issue":"11","key":"1684_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277061","volume":"17","author":"W Chen","year":"2022","unstructured":"Chen W, Yu Y, Liu Y, Song C, Chen H, Tang C, Song Y, Zhang X (2022) Ursolic acid regulates gut microbiota and corrects the imbalance of Th17\/Treg cells in T1DM rats. PLoS One 17(11):e0277061","journal-title":"PLoS One"},{"issue":"1","key":"1684_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07936-y","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Liu Y, Li Y, Li D, Mei Z, Deng Y (2025) Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death Dis 16(1):652. https:\/\/doi.org\/10.1038\/s41419-025-07936-y","journal-title":"Cell Death Dis"},{"issue":"10","key":"1684_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s40262-023-01301-y","volume":"62","author":"C Chevalier","year":"2023","unstructured":"Chevalier C, Fouqueray P, Bolze S (2023) Imeglimin: a clinical pharmacology review. Clin Pharmacokinet 62(10):1393\u20131411. https:\/\/doi.org\/10.1007\/s40262-023-01301-y","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1684_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s13318-020-00642-4","volume":"45","author":"C Chevalier","year":"2020","unstructured":"Chevalier C, Perrimond-Dauchy S, Dubourg J, Fouqueray P, Bolze S (2020) Lack of drug-drug interaction between Cimetidine, a renal transporter inhibitor, and Imeglimin, a novel oral antidiabetic drug, in healthy volunteers. Eur J Drug Metab Pharmacokinet 45(6):725\u2013733. https:\/\/doi.org\/10.1007\/s13318-020-00642-4","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"1684_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01011-y","volume":"31","author":"V Chew","year":"2024","unstructured":"Chew V, Chuang C-H, Hsu C (2024) Translational research on drug development and biomarker discovery for hepatocellular carcinoma. J Biomed Sci 31(1):22. https:\/\/doi.org\/10.1186\/s12929-024-01011-y","journal-title":"J Biomed Sci"},{"key":"1684_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104492","volume":"130","author":"VB Chine","year":"2019","unstructured":"Chine VB, Au NPB, Ma CHE (2019) Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy. Neurobiol Dis 130:104492. https:\/\/doi.org\/10.1016\/j.nbd.2019.104492","journal-title":"Neurobiol Dis"},{"key":"1684_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02655-9","author":"J Chow","year":"2025","unstructured":"Chow J, Lim W, Li L, Yu Q, Zhong Y, Wang Z, Shah SAA, Zhu C, Yan S, Liu H, Hu X, Gao L, Wang S, Liu J, Ma G (2025) Evaluation and comparison of efficacy and safety of mitochondrial modulator (Imeglimin) and DPP-4 inhibitors in patients with type 2 diabetes mellitus: a bayesian network meta-analysis. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02655-9","journal-title":"J Endocrinol Invest"},{"key":"1684_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152456","volume":"779","author":"S Chughtai","year":"2025","unstructured":"Chughtai S, Doyle D, Tata S, Ram D, Oymagil I (2025) Chemotherapy-induced cognitive impairment: mechanisms, emerging biomarkers, and therapeutic interventions. Biochem Biophys Res Commun 779:152456. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152456","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1684_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1124\/dmd.120.000154","volume":"48","author":"C Cl\u00e9mence","year":"2020","unstructured":"Cl\u00e9mence C, Fouqueray P, S\u00e9bastien B (2020) In vitro investigation, pharmacokinetics, and disposition of Imeglimin, a novel oral antidiabetic drug, in preclinical species and humans. Drug Metab Dispos 48(12):1330\u20131346. https:\/\/doi.org\/10.1124\/dmd.120.000154","journal-title":"Drug Metab Dispos"},{"key":"1684_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143106","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Beltr\u00e1n-Velasco AI, Redondo-Fl\u00f3rez L, Mart\u00edn-Rodr\u00edguez A, Y\u00e1\u00f1ez-Sep\u00falveda R, Tornero-Aguilera JF (2023a) Neuro-vulnerability in energy metabolism regulation: a comprehensive narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu15143106","journal-title":"Nutrients"},{"issue":"9","key":"1684_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092488","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Ramos-Campo DJ, Belinch\u00f3n-deMiguel P, Martinez-Guardado I, Dalamitros AA, Y\u00e1\u00f1ez-Sep\u00falveda R, Mart\u00edn-Rodr\u00edguez A, Tornero-Aguilera JF (2023b) Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities. Biomedicines 11(9):2488","journal-title":"Biomedicines"},{"key":"1684_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbi.2023.10.013","volume":"115","author":"MR Davies","year":"2024","unstructured":"Davies MR, Greenberg Z, van Vuurden DG, Cross CB, Zannettino ACW, Bardy C, Wardill HR (2024) More than a small adult brain: lessons from chemotherapy-induced cognitive impairment for modelling paediatric brain disorders. Brain Behav Immun 115:229\u2013247. https:\/\/doi.org\/10.1016\/j.bbi.2023.10.013","journal-title":"Brain Behav Immun"},{"issue":"s1","key":"1684_CR34","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.3233\/JAD-240069","volume":"101","author":"SM de la Monte","year":"2024","unstructured":"de la Monte SM (2024) Conquering insulin network dysfunctions in Alzheimer\u2019s disease: where are we today? J Alzheimers Dis 101(s1):S317\u2013S343","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1684_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-10-12","volume":"10","author":"ECM de Lange","year":"2013","unstructured":"de Lange ECM (2013) The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects. Fluids Barriers CNS 10(1):12. https:\/\/doi.org\/10.1186\/2045-8118-10-12","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"1684_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cpt.2545","volume":"111","author":"ECM de Lange","year":"2022","unstructured":"de Lange ECM, Hammarlund Udenaes M (2022) Understanding the blood-brain barrier and beyond: challenges and opportunities for novel CNS therapeutics. Clin Pharmacol Ther 111(4):758\u2013773. https:\/\/doi.org\/10.1002\/cpt.2545","journal-title":"Clin Pharmacol Ther"},{"key":"1684_CR37","unstructured":"De Luca F (2022) In vivo evaluation of the neuroprotective effects of a medicinal mushroom blend on breast metastases. cellular and molecular studies in CNS and lung"},{"issue":"2","key":"1684_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.17925\/ee.2021.17.2.88","volume":"17","author":"J Doupis","year":"2021","unstructured":"Doupis J, Baris N, Avramidis K (2021) Imeglimin: a new promising and effective weapon in the treatment of type 2 diabetes. TouchREV Endocrinol 17(2):88\u201391. https:\/\/doi.org\/10.17925\/ee.2021.17.2.88","journal-title":"TouchREV Endocrinol"},{"issue":"1","key":"1684_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12916-024-03775-4","volume":"22","author":"T Duraj","year":"2024","unstructured":"Duraj T, Kalamian M, Zuccoli G, Maroon JC, D\u2019Agostino DP, Scheck AC, Poff A, Winter SF, Hu J, Klement RJ, Hickson A, Lee DC, Cooper I, Kofler B, Schwartz KA, Phillips MCL, Champ CE, Zupec-Kania B, Tan-Shalaby J, Serfaty FM, Omene E, Arismendi-Morillo G, Kiebish M, Cheng R, El-Sakka AM, Pflueger A, Mathews EH, Worden D, Shi H, Cincione RI, Spinosa JP, Slocum AK, Iyikesici MS, Yanagisawa A, Pilkington GJ, Chaffee A, Abdel-Hadi W, Elsamman AK, Klein P, Hagihara K, Clemens Z, Yu GW, Evangeliou AE, Nathan JK, Smith K, Fortin D, Dietrich J, Mukherjee P, Seyfried TN (2024) Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med 22(1):578. https:\/\/doi.org\/10.1186\/s12916-024-03775-4","journal-title":"BMC Med"},{"key":"1684_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780199694938.001.0001","volume-title":"Clinical Pharmacology for Prescribing","author":"SR Emmett","year":"2019","unstructured":"Emmett SR, Hill N, Dajas-Bailador F (2019) Clinical Pharmacology for Prescribing. Oxford University Press"},{"key":"1684_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111143","volume":"220","author":"Y Fan","year":"2025","unstructured":"Fan Y, Luan X, Wang X, Li H, Zhao H, Li S, Li X, Qiu Z (2025) Exploring the association between BDNF related signaling pathways and depression: a literature review. Brain Res Bull 220:111143. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111143","journal-title":"Brain Res Bull"},{"key":"1684_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071726","author":"B Fleming","year":"2023","unstructured":"Fleming B, Edison P, Kenny L (2023) Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management. BMJ. https:\/\/doi.org\/10.1136\/bmj-2022-071726","journal-title":"BMJ"},{"issue":"3","key":"1684_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/antiox11030501","volume":"11","author":"J Fujii","year":"2022","unstructured":"Fujii J, Homma T, Osaki T (2022) Superoxide radicals in the execution of cell death. Antioxidants 11(3):501","journal-title":"Antioxidants"},{"issue":"6","key":"1684_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060943","volume":"11","author":"G Galizzi","year":"2022","unstructured":"Galizzi G, Di Carlo M (2022) Insulin and its key role for mitochondrial function\/dysfunction and quality control: a shared link between dysmetabolism and neurodegeneration. Biology 11(6):943","journal-title":"Biology"},{"issue":"1","key":"1684_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03033-7","volume":"21","author":"L Gao","year":"2024","unstructured":"Gao L, Peng L, Wang J, Zhang JH, Xia Y (2024) Mitochondrial stress: a key role of neuroinflammation in stroke. J Neuroinflammation 21(1):44. https:\/\/doi.org\/10.1186\/s12974-024-03033-7","journal-title":"J Neuroinflammation"},{"issue":"23","key":"1684_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312816","volume":"22","author":"L Gebauer","year":"2021","unstructured":"Gebauer L, Jensen O, Neif M, Brockm\u00f6ller J, D\u00fccker C (2021) Overlap and specificity in the substrate spectra of human monoamine transporters and organic cation transporters 1, 2, and 3. Int J Mol Sci 22(23):12816","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1684_CR47","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1039\/D3MD00085K","volume":"14","author":"A Gupta","year":"2023","unstructured":"Gupta A, Bhat HR, Singh UP (2023) Discovery of imeglimin-inspired novel 1, 3, 5-triazine derivatives as antidiabetic agents in streptozotocin-induced diabetes in Wistar rats via inhibition of DPP-4. RSC Med Chem 14(8):1512\u20131536","journal-title":"RSC Med Chem"},{"issue":"6","key":"1684_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12026-022-09307-7","volume":"70","author":"P Gupta","year":"2022","unstructured":"Gupta P, Makkar TK, Goel L, Pahuja M (2022) Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunol Res 70(6):725\u2013741","journal-title":"Immunol Res"},{"issue":"10","key":"1684_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0335888","volume":"20","author":"N Gyoutoku","year":"2025","unstructured":"Gyoutoku N, Inoguchi Y, Rikitake J, Demiya M, Gobaru M, Nagayama A, Iwata S, Hasuzawa N, Nakayama H, Ashida K, Nomura M (2025) Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes. PLoS One 20(10):e0335888. https:\/\/doi.org\/10.1371\/journal.pone.0335888","journal-title":"PLoS One"},{"issue":"3","key":"1684_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/dom.14277","volume":"23","author":"S Hallakou-Bozec","year":"2021","unstructured":"Hallakou-Bozec S, Vial G, Kergoat M, Fouqueray P, Bolze S, Borel AL, Fontaine E, Moller DE (2021) Mechanism of action of imeglimin: a novel therapeutic agent for type 2 diabetes. Diabetes Obes Metab 23(3):664\u2013673. https:\/\/doi.org\/10.1111\/dom.14277","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1684_CR51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/neuroglia5040027","volume":"5","author":"AR Hasan","year":"2024","unstructured":"Hasan AR, Tasnim F, Aktaruzzaman M, Islam MT, Rayhan R, Brishti A, Hur J, Porter JE, Raihan MO (2024) The alteration of microglial calcium homeostasis in central nervous system disorders: a comprehensive review. Neuroglia 5(4):410\u2013444","journal-title":"Neuroglia"},{"issue":"22","key":"1684_CR52","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.3390\/cancers15225331","volume":"15","author":"D Haywood","year":"2023","unstructured":"Haywood D, Dauer E, Baughman FD, Lawrence BJ, Rossell SL, Hart NH, O\u2019Connor M (2023) Is my brain ever going to work fully again? Challenges and needs of cancer survivors with persistent cancer-related cognitive impairment. Cancers 15(22):5331","journal-title":"Cancers"},{"issue":"8","key":"1684_CR53","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/ijms23084153","volume":"23","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Alomari S, Tyler BM (2022) Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci 23(8):4153","journal-title":"Int J Mol Sci"},{"key":"1684_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177937","volume":"1003","author":"T Hou","year":"2025","unstructured":"Hou T, Zhang J, Shi W (2025) Mechanisms and clinical perspectives on imeglimin for insulin resistance in obese patients. Eur J Pharmacol 1003:177937. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177937","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1684_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27689-y","volume":"13","author":"K Hozumi","year":"2023","unstructured":"Hozumi K, Sugawara K, Ishihara T, Ishihara N, Ogawa W (2023) Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes. Sci Rep 13(1):746. https:\/\/doi.org\/10.1038\/s41598-023-27689-y","journal-title":"Sci Rep"},{"issue":"2","key":"1684_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41386-019-0551-0","volume":"45","author":"K Huang","year":"2020","unstructured":"Huang K, Lin Y, Yang L, Wang Y, Cai S, Pang L, Wu X, Huang L, Alzheimer\u2019s Disease Neuroimaging I (2020) A multipredictor model to predict the conversion of mild cognitive impairment to Alzheimer\u2019s disease by using a predictive nomogram. Neuropsychopharmacology 45(2):358\u2013366. https:\/\/doi.org\/10.1038\/s41386-019-0551-0","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1684_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2022.100002","volume":"10","author":"Q Huang","year":"2022","unstructured":"Huang Q, Liao C, Ge F, Ao J, Liu T (2022) Acetylcholine bidirectionally regulates learning and memory. J Neurorestoratol 10(2):100002","journal-title":"J Neurorestoratol"},{"key":"1684_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107394","volume":"208","author":"K Hushmandi","year":"2024","unstructured":"Hushmandi K, Einollahi B, Aow R, Suhairi SB, Klionsky DJ, Aref AR, Reiter RJ, Makvandi P, Rabiee N, Xu Y, Nabavi N, Saadat SH, Farahani N, Kumar AP (2024) Investigating the interplay between mitophagy and diabetic neuropathy: uncovering the hidden secrets of the disease pathology. Pharmacol Res 208:107394. https:\/\/doi.org\/10.1016\/j.phrs.2024.107394","journal-title":"Pharmacol Res"},{"issue":"11","key":"1684_CR59","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00213-021-05977-7","volume":"238","author":"J John","year":"2021","unstructured":"John J, Kinra M, Mudgal J, Viswanatha GL, Nandakumar K (2021) Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology 238(11):3025\u20133053. https:\/\/doi.org\/10.1007\/s00213-021-05977-7","journal-title":"Psychopharmacology"},{"key":"1684_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13111415","author":"K Kaji","year":"2024","unstructured":"Kaji K, Takeda S, Iwai S, Nishimura N, Sato S, Namisaki T, Akahane T, Yoshiji H (2024a) Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated steatohepatitis. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13111415","journal-title":"Antioxidants"},{"issue":"11","key":"1684_CR61","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/antiox13111415","volume":"13","author":"K Kaji","year":"2024","unstructured":"Kaji K, Takeda S, Iwai S, Nishimura N, Sato S, Namisaki T, Akahane T, Yoshiji H (2024b) Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated steatohepatitis. Antioxidants 13(11):1415","journal-title":"Antioxidants"},{"issue":"6","key":"1684_CR62","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1111\/dom.16336","volume":"27","author":"K Kaku","year":"2025","unstructured":"Kaku K, Shimoda M, Osonoi T, Iwamoto M, Kaneto H (2025) Efficacy and safety of imeglimin add-on to DPP-4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: an interim analysis of the randomised, double-blind FAMILIAR trial. Diabetes Obes Metab 27(6):3212\u20133222. https:\/\/doi.org\/10.1111\/dom.16336","journal-title":"Diabetes Obes Metab"},{"key":"1684_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.003","volume":"346","author":"N Katila","year":"2022","unstructured":"Katila N, Duwa R, Bhurtel S, Khanal S, Maharjan S, Jeong J-H, Lee S, Choi D-Y, Yook S (2022) Enhancement of blood\u2013brain barrier penetration and the neuroprotective effect of resveratrol. J Control Release 346:1\u201319. https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.003","journal-title":"J Control Release"},{"key":"1684_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030284","author":"H Kato","year":"2024","unstructured":"Kato H, Iwashita K, Iwasa M, Kato S, Yamakage H, Suganami T, Tanaka M, Satoh-Asahara N (2024) Imeglimin exhibits novel anti-inflammatory effects on high-glucose-stimulated mouse microglia through ULK1-mediated suppression of the TXNIP-NLRP3 axis. Cells. https:\/\/doi.org\/10.3390\/cells13030284","journal-title":"Cells"},{"key":"1684_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252211955","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024a) Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252211955","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1684_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252211955","volume":"25","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024b) Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci 25(22):11955","journal-title":"Int J Mol Sci"},{"key":"1684_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae268","author":"A Kerkmann","year":"2025","unstructured":"Kerkmann A, Schinke C, Dordevic A, Kern J, Bangemann N, Finck J, Blohmer JU, Ruprecht K, G\u00f6pfert JC, Otto C, Materne B, Endres M, Boehmerle W, Huehnchen P (2025) Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyae268","journal-title":"Oncologist"},{"issue":"2","key":"1684_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40265-020-01434-5","volume":"81","author":"C Konkwo","year":"2021","unstructured":"Konkwo C, Perry RJ (2021) Imeglimin: current development and future potential in type 2 diabetes. Drugs 81(2):185\u2013190","journal-title":"Drugs"},{"issue":"1","key":"1684_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-019-0104-9","volume":"55","author":"MG Kotb","year":"2019","unstructured":"Kotb MG, Soliman AER, Ibrahim RI, Said RMM, El Din MMW (2019) Chemotherapy-induced cognitive impairment in hematological malignancies. Egypt J Neurol Psychiatr Neurosurg 55(1):56. https:\/\/doi.org\/10.1186\/s41983-019-0104-9","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"1","key":"1684_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04036-0","volume":"15","author":"D Kumar","year":"2024","unstructured":"Kumar D, Tanwar R (2024) World\u2019s first: stem cell therapy reverses diabetes. Stem Cell Res Ther 15(1):487. https:\/\/doi.org\/10.1186\/s13287-024-04036-0","journal-title":"Stem Cell Res Ther"},{"key":"1684_CR71","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1134\/S2635167624602420","volume":"19","author":"A Kuvirchenkova","year":"2025","unstructured":"Kuvirchenkova A, Goleva T, Sukhinov D, Sergeeva Y, Vasilov R (2025) Effect of C-Phycocyanin on isolated mitochondria. Nanobiotechnol Rep 19:1023\u20131029. https:\/\/doi.org\/10.1134\/S2635167624602420","journal-title":"Nanobiotechnol Rep"},{"issue":"1","key":"1684_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42","journal-title":"Transl Neurodegener"},{"issue":"9","key":"1684_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41574-024-00992-y","volume":"20","author":"HT Langer","year":"2024","unstructured":"Langer HT, Rohm M, Goncalves MD, Sylow L (2024) AMPK as a mediator of tissue preservation: time for a shift in dogma? Nat Rev Endocrinol 20(9):526\u2013540. https:\/\/doi.org\/10.1038\/s41574-024-00992-y","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1684_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau K, Kotzur R, Richter F (2024) Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy. Transl Neurodegener 13(1):37. https:\/\/doi.org\/10.1186\/s40035-024-00430-z","journal-title":"Transl Neurodegener"},{"issue":"24","key":"1684_CR75","doi-asserted-by":"publisher","first-page":"13315","DOI":"10.3390\/ijms222413315","volume":"22","author":"KH Lee","year":"2021","unstructured":"Lee KH, Cha M, Lee BH (2021) Crosstalk between neuron and glial cells in oxidative injury and neuroprotection. Int J Mol Sci 22(24):13315","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1684_CR76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","volume":"23","author":"S Li","year":"2022","unstructured":"Li S, Sheng Z-H (2022) Energy matters: presynaptic metabolism and the maintenance of synaptic transmission. Nat Rev Neurosci 23(1):4\u201322","journal-title":"Nat Rev Neurosci"},{"key":"1684_CR77","doi-asserted-by":"publisher","first-page":"116755","DOI":"10.1016\/j.biopha.2024.116755","volume":"175","author":"Y Li","year":"2024","unstructured":"Li Y, Lou N, Liu X, Zhuang X, Chen S (2024) Exploring new mechanisms of Imeglimin in diabetes treatment: amelioration of mitochondrial dysfunction. Biomed Pharmacother 175:116755. https:\/\/doi.org\/10.1016\/j.biopha.2024.116755","journal-title":"Biomed Pharmacother"},{"key":"1684_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100016","author":"J Liao","year":"2025","unstructured":"Liao J, He W, Li L, Wang J, Gong L, Zhang Q, Lin Z (2025) Mitochondria in brain diseases: bridging structural-mechanistic insights into precision-targeted therapies. Cell Biomaterials. https:\/\/doi.org\/10.1016\/j.celbio.2025.100016","journal-title":"Cell Biomaterials"},{"issue":"1","key":"1684_CR79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13046-019-1214-z","volume":"38","author":"J Lin","year":"2019","unstructured":"Lin J, Xia L, Liang J, Han Y, Wang H, Oyang L, Tan S, Tian Y, Rao S, Chen X (2019) The roles of glucose metabolic reprogramming in chemo-and radio-resistance. J Exp Clin Cancer Res 38(1):218","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"1684_CR80","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"M-m Lin","year":"2022","unstructured":"Lin M-m, Liu N, Qin Z-h, Wang Y (2022) Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 43(10):2439\u20132447","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"1684_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112993","volume":"11","author":"G Lisco","year":"2023","unstructured":"Lisco G, De Tullio A, Iovino M, Disoteo O, Guastamacchia E, Giagulli VA, Triggiani V (2023) Dopamine in the regulation of glucose homeostasis, pathogenesis of type 2 diabetes, and chronic conditions of impaired dopamine activity\/metabolism: implication for pathophysiological and therapeutic purposes. Biomedicines 11(11):2993","journal-title":"Biomedicines"},{"issue":"1","key":"1684_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu H, Wang S, Wang J, Guo X, Song Y, Fu K, Gao Z, Liu D, He W, Yang L-L (2025a) Energy metabolism in health and diseases. Signal Transduct Target Ther 10(1):69. https:\/\/doi.org\/10.1038\/s41392-025-02141-x","journal-title":"Signal Transduct Target Ther"},{"key":"1684_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202403019","author":"S Liu","year":"2025","unstructured":"Liu S, Liu Z, Lei H, Miao YB, Chen J (2025b) Programmable nanomodulators for precision therapy, engineering tumor metabolism to enhance therapeutic efficacy. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202403019","journal-title":"Adv Healthc Mater"},{"key":"1684_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101457","volume":"31","author":"Q Luo","year":"2025","unstructured":"Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J, Kalvakolanu DV, Cong X, Zhang J, Zhang L, Guo B, Duo Y (2025) Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system. Mater Today Bio 31:101457. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101457","journal-title":"Mater Today Bio"},{"issue":"5","key":"1684_CR85","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/brainsci13050784","volume":"13","author":"S Madireddy","year":"2023","unstructured":"Madireddy S, Madireddy S (2023) Therapeutic strategies to ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation. Brain Sci 13(5):784","journal-title":"Brain Sci"},{"issue":"5","key":"1684_CR86","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/ijms23052687","volume":"23","author":"M Michailidis","year":"2022","unstructured":"Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V (2022) Alzheimer\u2019s disease as type 3 diabetes: common pathophysiological mechanisms between alzheimer\u2019s disease and type 2 diabetes. Int J Mol Sci 23(5):2687","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1684_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01610-7","volume":"20","author":"K Mitusova","year":"2022","unstructured":"Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS (2022) Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnology 20(1):412. https:\/\/doi.org\/10.1186\/s12951-022-01610-7","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"1684_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2023.100334","volume":"11","author":"M Miyashita","year":"2024","unstructured":"Miyashita M (2024) Chemotherapy-related cognitive impairment: what we need to know and what we can do. Asia Pac J Oncol Nurs 11(1):100334. https:\/\/doi.org\/10.1016\/j.apjon.2023.100334","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"3","key":"1684_CR89","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13443","volume":"31","author":"AA Mohamed Yusoff","year":"2025","unstructured":"Mohamed Yusoff AA, Mohd Khair SZN, Abd Radzak SM (2025) Mitochondrial DNA copy number alterations: key players in the complexity of glioblastoma. Mol Med Rep 31(3):78","journal-title":"Mol Med Rep"},{"issue":"6","key":"1684_CR90","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1111\/brv.12764","volume":"96","author":"G Morciano","year":"2021","unstructured":"Morciano G, Naumova N, Koprowski P, Valente S, Sard\u00e3o VA, Potes Y, Rimessi A, Wieckowski MR, Oliveira PJ (2021) The mitochondrial permeability transition pore: an evolving concept critical for cell life and death. Biol Rev 96(6):2489\u20132521","journal-title":"Biol Rev"},{"key":"1684_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020a.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM, Abdel-Maged A-S, Wahdan SA, Gad AM, Azab SS (2020a) Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci 258:118071. https:\/\/doi.org\/10.1016\/j.lfs.2020a.118071","journal-title":"Life Sci"},{"key":"1684_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020b.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM, Abdel-Maged AE, Wahdan SA, Gad AM, Azab SS (2020b) Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci 258:118071. https:\/\/doi.org\/10.1016\/j.lfs.2020b.118071","journal-title":"Life Sci"},{"issue":"8","key":"1684_CR93","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/febs.16151","volume":"289","author":"R Muraleedharan","year":"2022","unstructured":"Muraleedharan R, Dasgupta B (2022) AMPK in the brain: its roles in glucose and neural metabolism. FEBS J 289(8):2247\u20132262","journal-title":"FEBS J"},{"key":"1684_CR94","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.toxrep.2023.04.015","volume":"10","author":"LC Murillo","year":"2023","unstructured":"Murillo LC, Sutachan JJ, Albarrac\u00edn SL (2023) An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI). Toxicol Rep 10:544\u2013553","journal-title":"Toxicol Rep"},{"issue":"53","key":"1684_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz004","volume":"2019","author":"BA Murphy","year":"2019","unstructured":"Murphy BA, Wulff-Burchfield E, Ghiam M, Bond SM, Deng J (2019) Chronic systemic symptoms in head and neck cancer patients. JNCI Monogr 2019(53):lgz004","journal-title":"JNCI Monogr"},{"issue":"11","key":"1684_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111824","volume":"10","author":"G Napolitano","year":"2021","unstructured":"Napolitano G, Fasciolo G, Venditti P (2021) Mitochondrial management of reactive oxygen species. Antioxidants 10(11):1824","journal-title":"Antioxidants"},{"issue":"6","key":"1684_CR97","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012075","volume":"12","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Ehrlich BE (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med 12(6):e12075. https:\/\/doi.org\/10.15252\/emmm.202012075","journal-title":"EMBO Mol Med"},{"key":"1684_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188913","author":"H Ohguro","year":"2025","unstructured":"Ohguro H, Watanabe M, Suzuki M, Ohara N, Ogawa T, Sato T, Yano T (2025) Imeglimin alleviates high-glucose-induced bioenergetic and oxidative stress thereby enhancing intercellular adhesion in H9c2 cardiomyocytes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26188913","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1684_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02202-5","volume":"21","author":"A Olatunde","year":"2021","unstructured":"Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti kumar V, Mishra AP, Sharifi-Rad J (2021) Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 21(1):499. https:\/\/doi.org\/10.1186\/s12935-021-02202-5","journal-title":"Cancer Cell Int"},{"key":"1684_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113118","volume":"324","author":"B Ongnok","year":"2020","unstructured":"Ongnok B, Chattipakorn N, Chattipakorn SC (2020) Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol 324:113118. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113118","journal-title":"Exp Neurol"},{"issue":"4","key":"1684_CR101","doi-asserted-by":"publisher","first-page":"418","DOI":"10.15386\/mpr-2458","volume":"95","author":"A Papadopoulou","year":"2022","unstructured":"Papadopoulou A, Govina O, Tsatsou I, Mantzorou M, Mantoudi A, Tsiou C, Adamakidou T (2022) Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy. Med Pharm Rep 95(4):418\u2013429. https:\/\/doi.org\/10.15386\/mpr-2458","journal-title":"Med Pharm Rep"},{"issue":"3","key":"1684_CR102","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41569-020-00451-x","volume":"18","author":"R Parameswaran","year":"2021","unstructured":"Parameswaran R, Al-Kaisey AM, Kalman JM (2021) Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol 18(3):210\u2013225","journal-title":"Nat Rev Cardiol"},{"key":"1684_CR103","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ctrv.2016.12.005","volume":"53","author":"JL Perez-Gracia","year":"2017","unstructured":"Perez-Gracia JL, Sanmamed MF, Bosch A, Pati\u00f1o-Garcia A, Schalper KA, Segura V, Bellmunt J, Tabernero J, Sweeney CJ, Choueiri TK, Mart\u00edn M, Fusco JP, Rodriguez-Ruiz ME, Calvo A, Prior C, Paz-Ares L, Pio R, Gonzalez-Billalabeitia E, Gonzalez Hernandez A, P\u00e1ez D, Piulats JM, Gurpide A, Andueza M, de Velasco G, Pazo R, Grande E, Nicolas P, Abad-Santos F, Garcia-Donas J, Castellano D, Pajares MJ, Suarez C, Colomer R, Montuenga LM, Melero I (2017) Strategies to design clinical studies to identify predictive biomarkers in cancer research. Cancer Treat Rev 53:79\u201397. https:\/\/doi.org\/10.1016\/j.ctrv.2016.12.005","journal-title":"Cancer Treat Rev"},{"key":"1684_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080647","author":"A Picca","year":"2020","unstructured":"Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E (2020) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants (Basel)"},{"key":"1684_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118402","author":"R Pramanik","year":"2024","unstructured":"Pramanik R, Dey A, Chakrabarty AK, Banerjee D, Narwaria A, Sharma S, Rai RK, Katiyar CK, Dubey SK (2024) Diabetes mellitus and Alzheimer\u2019s disease: understanding disease mechanisms, their correlation, and promising dual activity of selected herbs. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2024.118402","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1684_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2024","unstructured":"Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y, Wang X, Liu Y, Tian Y, Yang Y (2024) Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther 9(1):50","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1684_CR107","first-page":"77","volume":"13","author":"K Rana","year":"2022","unstructured":"Rana K, Gautam P (2022) A review on antioxidants as therapeutic in use of oxidative stress and neurodegenerative disease. Int J Pharm Qual Assur 13(1):77\u201382","journal-title":"Int J Pharm Qual Assur"},{"key":"1684_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.acr.2022.04.001","volume":"155","author":"V Rao","year":"2022","unstructured":"Rao V, Bhushan R, Kumari P, Cheruku SP, Ravichandiran V, Kumar N (2022) Chemobrain: a review on mechanistic insight, targets and treatments. Adv Cancer Res 155:29\u201376","journal-title":"Adv Cancer Res"},{"issue":"6","key":"1684_CR109","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbadis.2019.02.007","volume":"1865","author":"X Ren","year":"2019","unstructured":"Ren X, Boriero D, Chaiswing L, Bondada S, St Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (chemobrain), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta Mol Basis Dis 1865(6):1088\u20131097. https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.007","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"19\u201320","key":"1684_CR110","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.1007\/s00018-021-03925-4","volume":"78","author":"NG Rummel","year":"2021","unstructured":"Rummel NG, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA (2021) Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNF\u03b1. Cell Mol Life Sci 78(19\u201320):6533\u20136540","journal-title":"Cell Mol Life Sci"},{"key":"1684_CR111","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/9781119790419.ch16","volume":"16","author":"AK Ryan","year":"2025","unstructured":"Ryan AK, Rich WW, Jansen PA, Allyn MM, Swindle-Reilly KE, Reilly AM (2025) Oxidative Stress in the Eye. Molecular Basis of Oxidative Stress: Chemistry, Toxicology, Disease Pathogenesis, Diagnosis, and Therapeutics 16:395\u2013415","journal-title":"Molecular Basis of Oxidative Stress: Chemistry, Toxicology, Disease Pathogenesis, Diagnosis, and Therapeutics"},{"key":"1684_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118056","volume":"187","author":"HN Sabbah","year":"2025","unstructured":"Sabbah HN, Alder NN, Sparagna GC, Bruce JE, Stauffer BL, Chao LH, Pitceathly RDS, Maack C, Marcinek DJ (2025) Contemporary insights into elamipretide\u2019s mitochondrial mechanism of action and therapeutic effects. Biomed Pharmacother 187:118056. https:\/\/doi.org\/10.1016\/j.biopha.2025.118056","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1684_CR113","first-page":"402","volume":"7","author":"NC Sabry","year":"2023","unstructured":"Sabry NC, Michel HE, Menze ET (2023) Chemotherapy and cognitive function: comprehensive review on methotrexate-induced chemobrain. Arch Pharm Sci Ain Shams Univ 7(2):402\u2013420","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"issue":"6","key":"1684_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/cells11060990","volume":"11","author":"S Saha","year":"2022","unstructured":"Saha S, Singh PK, Roy P, Kakar SS (2022) Cardiac cachexia: unaddressed aspect in cancer patients. Cells 11(6):990","journal-title":"Cells"},{"key":"1684_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100047","volume":"2","author":"K Sahu","year":"2021","unstructured":"Sahu K, Langeh U, Singh C, Singh A (2021) Crosstalk between anticancer drugs and mitochondrial functions. Curr Res Pharmacol Drug Discov 2:100047. https:\/\/doi.org\/10.1016\/j.crphar.2021.100047","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"1684_CR116","doi-asserted-by":"publisher","first-page":"1585834","DOI":"10.3389\/fendo.2025.1585834","volume":"16","author":"A Satheesan","year":"2025","unstructured":"Satheesan A, Kumar J, Leela KV, Murugesan R (2025a) Effect of Imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study. Front Endocrinol (Lausanne) 16:1585834. https:\/\/doi.org\/10.3389\/fendo.2025.1585834","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1684_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1585834","author":"A Satheesan","year":"2025","unstructured":"Satheesan A, Kumar J, Leela KV, Murugesan R (2025b) Effect of imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2025.1585834","journal-title":"Front Endocrinol"},{"key":"1684_CR118","first-page":"1","volume-title":"Handbook of neurotoxicity","author":"J Segura-Aguilar","year":"2022","unstructured":"Segura-Aguilar J, Paris I (2022) Mechanisms of dopamine oxidation and Parkinson\u2019s disease. Handbook of neurotoxicity. Springer, pp 1\u201336"},{"issue":"23","key":"1684_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312697","volume":"22","author":"MJ Sekeres","year":"2021","unstructured":"Sekeres MJ, Bradley-Garcia M, Martinez-Canabal A, Winocur G (2021) Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions. Int J Mol Sci 22(23):12697","journal-title":"Int J Mol Sci"},{"key":"1684_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106283","volume":"176","author":"I Semendric","year":"2025","unstructured":"Semendric I, Barker TH, Haller OJ, Pollock D, Collins-Praino LE, Whittaker AL (2025) Prevalence of cancer-related cognitive impairment in pediatric patients and survivors of non-CNS cancers: a systematic review and meta-analysis. Neurosci Biobehav Rev 176:106283. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106283","journal-title":"Neurosci Biobehav Rev"},{"key":"1684_CR121","volume":"111","author":"PW Sessions","year":"2022","unstructured":"Sessions PW (2022) American Society for Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther 111:S5","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1684_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/biology10040268","volume":"10","author":"G Sharma","year":"2021","unstructured":"Sharma G, Pfeffer G, Shutt TE (2021) Genetic neuropathy due to impairments in mitochondrial dynamics. Biology 10(4):268","journal-title":"Biology"},{"issue":"2","key":"1684_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahr.2025.100226","volume":"5","author":"V Sharma","year":"2025","unstructured":"Sharma V, Aran KR (2025) Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer\u2019s disease pathophysiology. Aging Health Res 5(2):100226. https:\/\/doi.org\/10.1016\/j.ahr.2025.100226","journal-title":"Aging Health Res"},{"key":"1684_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-025-03902-x","author":"SM Shireen","year":"2025","unstructured":"Shireen SM, Bhavya E, Parthiban R (2025) Imeglimin systematic review: a novel therapeutic approach for type 2 diabetes-unveiling benefits on \u03b2-cell function, insulin sensitivity, and potential long-term glycaemic control (HbA1c). Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-025-03902-x","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1684_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01922-2","volume":"17","author":"Q Song","year":"2025","unstructured":"Song Q, Mae R, Kutbi E, AlJurayyan AN, Abu-Zaid A, Jamilian P, Falahatzadeh M (2025) Imeglimin as an effective therapeutic approach in management of type 2 diabetes mellitus: an umbrella review and systematic review, meta-regression and meta-analysis. Diabetol Metab Syndr 17(1):357. https:\/\/doi.org\/10.1186\/s13098-025-01922-2","journal-title":"Diabetol Metab Syndr"},{"issue":"17","key":"1684_CR126","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2174\/0113895575260225230921062013","volume":"24","author":"J Swain","year":"2024","unstructured":"Swain J, Jadhao P, Sravya S, Teli B, Lavanya K, Singh J, Sahoo A, Das S (2024) Mitochondrial dysfunction and imeglimin: a new ray of hope for the treatment of type-2 diabetes mellitus. Mini Rev Med Chem 24(17):1575\u20131589","journal-title":"Mini Rev Med Chem"},{"key":"1684_CR127","unstructured":"Taber A (2020) Neurocognitive risk factors and current intervention strategies for survivors of pediatric acute lymphoblastic Leukemia"},{"issue":"8","key":"1684_CR128","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/molecules26082179","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib WH, Mahmod AI, Abuarab SF, Hasen E, Munaim AA, Haif SK, Ayyash AM, Khater S, AL-Yasari IH, Kury LTA (2021) Diabetes and cancer: metabolic association, therapeutic challenges, and the role of natural products. Molecules 26(8):2179","journal-title":"Molecules"},{"issue":"3","key":"1684_CR129","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/nano9030371","volume":"9","author":"DM Teleanu","year":"2019","unstructured":"Teleanu DM, Negut I, Grumezescu V, Grumezescu AM, Teleanu RI (2019) Nanomaterials for drug delivery to the central nervous system. Nanomaterials 9(3):371","journal-title":"Nanomaterials"},{"issue":"11","key":"1684_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu A-G, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23(11):5938","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1684_CR131","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/polym12123055","volume":"12","author":"S Thangudu","year":"2020","unstructured":"Thangudu S, Cheng F-Y, Su C-H (2020) Advancements in the blood\u2013brain barrier penetrating nanoplatforms for brain related disease diagnostics and therapeutic applications. Polymers 12(12):3055","journal-title":"Polymers"},{"key":"1684_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2025.102876","volume":"47","author":"JO Thomas","year":"2025","unstructured":"Thomas JO, Margaret II, Dehou RJ, Ocholi SS (2025) Nano-phyto formulations for overcoming drug resistance in brain cancer: a translational roadmap. Mater Today Chem 47:102876. https:\/\/doi.org\/10.1016\/j.mtchem.2025.102876","journal-title":"Mater Today Chem"},{"key":"1684_CR133","unstructured":"Toczyska K (2022) Direct effects of selective serotonin reuptake Inhibitors, Fluoxetine, Sertraline and Paroxetine, and atypical Antipsychotics, Aripiprazole and Clozapine, on islet beta cell mass and function. King\u2019s College London"},{"issue":"1","key":"1684_CR134","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12877-023-04574-x","volume":"23","author":"S Tomaszewski Farias","year":"2023","unstructured":"Tomaszewski Farias S, Fox J, Dulaney H, Chan M, Namboodiri S, Harvey D, Weakley A, Rahman S, Luna C, Beech B (2023) Memory support training and lifestyle modifications to promote healthy aging in persons at risk for Alzheimer\u2019s disease: a digital application supported intervention (Brain Boosters). BMC Geriatr 23(1):881","journal-title":"BMC Geriatr"},{"issue":"9","key":"1684_CR135","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M, S\u00e1 J, da Cruz e Silva O (2022) Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett 596(9):1095\u20131110","journal-title":"FEBS Lett"},{"key":"1684_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37545","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Kharkwal G, Mishra R, Singh G (2024) Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling in heavy metals-induced oxidative stress. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37545","journal-title":"Heliyon"},{"issue":"3","key":"1684_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030944","volume":"26","author":"C Tung","year":"2025","unstructured":"Tung C, Varzideh F, Farroni E, Mone P, Kansakar U, Jankauskas SS, Santulli G (2025) Elamipretide: a review of its structure, mechanism of action, and therapeutic potential. Int J Mol Sci 26(3):944","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1684_CR138","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66322","volume":"16","author":"A Uto","year":"2024","unstructured":"Uto A, Ishinoda Y, Asaga T, Tanahashi Y, Kobayashi A, Meshino H, Okazaki M, Tomita K, Kasuga A, Oshima N (2024) Imeglimin for type 2 diabetes mellitus: its efficacy and insight into the potential benefit for renal and liver function. Cureus 16(8):e66322. https:\/\/doi.org\/10.7759\/cureus.66322","journal-title":"Cureus"},{"key":"1684_CR139","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mito.2023.09.003","volume":"73","author":"H Verma","year":"2023","unstructured":"Verma H, Gangwar P, Yadav A, Yadav B, Rao R, Kaur S, Kumar P, Dhiman M, Taglialatela G, Mantha AK (2023) Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer\u2019s disease. Mitochondrion 73:19\u201329","journal-title":"Mitochondrion"},{"issue":"1","key":"1684_CR140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener 11(1):3","journal-title":"Transl Neurodegener"},{"key":"1684_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.693051","volume":"11","author":"X Wan","year":"2021","unstructured":"Wan X, Garg NJ (2021) Sirtuin control of mitochondrial dysfunction, oxidative stress, and inflammation in Chagas disease models. Front Cell Infect Microbiol 11:693051","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1684_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00284-5","volume":"6","author":"L Wang","year":"2025","unstructured":"Wang L, Zhou X, Lu T (2025) Role of mitochondria in physiological activities, diseases, and therapy. Mol Biomed 6(1):42. https:\/\/doi.org\/10.1186\/s43556-025-00284-5","journal-title":"Mol Biomed"},{"key":"1684_CR143","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Nurgali K, Abalo R (2022a) Mechanisms of Chemotherapy-Induced neurotoxicity. Front Pharmacol 13:750507. https:\/\/doi.org\/10.3389\/fphar.2022.750507","journal-title":"Front Pharmacol"},{"key":"1684_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.750507","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Nurgali K, Abalo R (2022b) Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.750507","journal-title":"Front Pharmacol"},{"issue":"5","key":"1684_CR145","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/1878-0261.13578","volume":"18","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xiao C, Li F, Huang W, You F, Li X (2024) Mitochondrial fusion-fission dynamics and its involvement in colorectal cancer. Mol Oncol 18(5):1058\u20131075. https:\/\/doi.org\/10.1002\/1878-0261.13578","journal-title":"Mol Oncol"},{"issue":"5","key":"1684_CR146","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/biology12050726","volume":"12","author":"H Yanai","year":"2023","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H (2023) Glucose-lowering effects of Imeglimin and its possible beneficial effects on diabetic complications. Biology 12(5):726","journal-title":"Biology"},{"issue":"1","key":"1684_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-023-00720-0","volume":"15","author":"S-Q Yang","year":"2023","unstructured":"Yang S-Q, Zhang L-X, Ge Y-J, Zhang J-W, Hu J-X, Shen C-Y, Lu A-P, Hou T-J, Cao D-S (2023) In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences. J Cheminform 15(1):48. https:\/\/doi.org\/10.1186\/s13321-023-00720-0","journal-title":"J Cheminform"},{"key":"1684_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24506","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga S, Fujita Y, Ishii A, Fukumoto Y, Arahata H, Kojima T, Ito M, Tanaka M, Saiki R, Koga Y (2015) Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.24506","journal-title":"Ann Neurol"},{"key":"1684_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107685","volume":"214","author":"M Yu","year":"2025","unstructured":"Yu M, Liu G, Chen W, Qiu Y, You N, Chen S, Wei Z, Ji L, Han M, Qin Z, Sun T, Wang D (2025) Choline metabolism in ischemic stroke: an underappreciated \u201ctwo-edged sword.\u201d Pharmacol Res 214:107685. https:\/\/doi.org\/10.1016\/j.phrs.2025.107685","journal-title":"Pharmacol Res"},{"issue":"5","key":"1684_CR150","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s12035-022-02765-y","volume":"59","author":"G Zemgulyte","year":"2022","unstructured":"Zemgulyte G, Umbrasas D, Cizas P, Jankeviciute S, Pampuscenko K, Grigaleviciute R, Rastenyte D, Borutaite V (2022) Imeglimin is neuroprotective against ischemic brain injury in Rats-a study evaluating neuroinflammation and mitochondrial functions. Mol Neurobiol 59(5):2977\u20132991. https:\/\/doi.org\/10.1007\/s12035-022-02765-y","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1684_CR151","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.jfda.2017.11.008","volume":"26","author":"W Zha","year":"2018","unstructured":"Zha W (2018) Transporter-mediated natural product\u2013drug interactions for the treatment of cardiovascular diseases. J Food Drug Anal 26(2):S32\u2013S44. https:\/\/doi.org\/10.1016\/j.jfda.2017.11.008","journal-title":"J Food Drug Anal"},{"key":"1684_CR152","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.2147\/jir.S483412","volume":"17","author":"S Zhang","year":"2024","unstructured":"Zhang S, Gao Z, Feng L, Li M (2024a) Prevention and treatment strategies for Alzheimer\u2019s disease: focusing on microglia and astrocytes in neuroinflammation. J Inflamm Res 17:7235\u20137259. https:\/\/doi.org\/10.2147\/jir.S483412","journal-title":"J Inflamm Res"},{"key":"1684_CR153","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S483412","author":"S Zhang","year":"2024","unstructured":"Zhang S, Gao Z, Feng L, Li M (2024b) Prevention and treatment strategies for Alzheimer\u2019s disease: focusing on microglia and astrocytes in neuroinflammation. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S483412","journal-title":"J Inflamm Res"},{"key":"1684_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.662242","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Alshakhshir N, Zhao L (2021) Glycolytic metabolism, brain resilience, and Alzheimer\u2019s disease. Front Neurosci 15:662242","journal-title":"Front Neurosci"},{"issue":"1","key":"1684_CR155","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43556-020-00012-1","volume":"2","author":"H Zhao","year":"2021","unstructured":"Zhao H, Li Y (2021) Cancer metabolism and intervention therapy. Mol Biomed 2(1):5","journal-title":"Mol Biomed"},{"issue":"1","key":"1684_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1627-9","volume":"16","author":"W Zhao","year":"2019","unstructured":"Zhao W, Xu Z, Cao J, Fu Q, Wu Y, Zhang X, Long Y, Zhang X, Yang Y, Li Y, Mi W (2019) Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. J Neuroinflammation 16(1):230. https:\/\/doi.org\/10.1186\/s12974-019-1627-9","journal-title":"J Neuroinflammation"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01684-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:02:17Z","timestamp":1772089337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01684-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":156,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01684-z","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"No ethical approval required in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"I hereby give my consent for the publication of the entitled \u201cRepurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation\u201d.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"51"}}